scout
Opinion|Videos|December 27, 2023

Recent Updates in NCCN Guidelines for the Treatment of Recurrent or Metastatic Cervical Cancer

Leslie M. Randall, MD, reviews updates to the NCCN guidelines for cervical cancer, including the use of pembrolizumab in the second and third-line settings, the results of the KEYNOTE-826 trial, and the potential role of induction chemotherapy with weekly carboplatin and paclitaxel in the treatment of locally advanced cervical cancer.

Episodes in this series

Newsletter

Stay up to date on the most recent and practice-changing oncology data


Latest CME